Gyre Therapeutics Files 8-K
Ticker: GYRE · Form: 8-K · Filed: Apr 28, 2025 · CIK: 1124105
| Field | Detail |
|---|---|
| Company | Gyre Therapeutics, Inc. (GYRE) |
| Form Type | 8-K |
| Filed Date | Apr 28, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: disclosure, financials
TL;DR
Gyre Therapeutics filed an 8-K on 4/28/25 covering Reg FD and financials.
AI Summary
On April 28, 2025, Gyre Therapeutics, Inc. filed an 8-K report. The filing primarily concerns Regulation FD Disclosure and Financial Statements and Exhibits. The company, formerly known as Catalyst Biosciences, Inc. and Targacept Inc., is incorporated in Delaware and headquartered in San Diego, California.
Why It Matters
This filing provides important updates on Gyre Therapeutics' financial and regulatory disclosures, which are crucial for investors to assess the company's current standing and future prospects.
Risk Assessment
Risk Level: low — The filing is a routine disclosure of financial statements and regulatory information, not indicating any immediate operational or financial distress.
Key Players & Entities
- GYRE THERAPEUTICS, INC. (company) — Registrant
- CATALYST BIOSCIENCES, INC. (company) — Former company name
- TARGACEPT INC (company) — Former company name
- April 28, 2025 (date) — Date of report
FAQ
What is the primary purpose of this 8-K filing for Gyre Therapeutics, Inc.?
The primary purpose of this 8-K filing is for Regulation FD Disclosure and to report Financial Statements and Exhibits.
When was the earliest event reported in this filing?
The earliest event reported in this filing was on April 28, 2025.
What is Gyre Therapeutics, Inc.'s principal executive office address?
Gyre Therapeutics, Inc.'s principal executive office is located at 12770 High Bluff Drive, Suite 150, San Diego, CA 92130.
What were Gyre Therapeutics, Inc.'s former company names?
Gyre Therapeutics, Inc.'s former company names were CATALYST BIOSCIENCES, INC. and TARGACEPT INC.
In which state is Gyre Therapeutics, Inc. incorporated?
Gyre Therapeutics, Inc. is incorporated in Delaware.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on April 28, 2025 regarding GYRE THERAPEUTICS, INC. (GYRE).